These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 3490612)
1. Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue. Baldessarini RJ; Kula NS; Francoeur D; Finklestein SP; Murphy F; Neumeyer JL Life Sci; 1986 Nov; 39(19):1765-77. PubMed ID: 3490612 [TBL] [Abstract][Full Text] [Related]
2. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations. Heikkila RE; Youngster SK; Manzino L; Cabbat FS; Duvoisin RC J Neurochem; 1985 Jan; 44(1):310-3. PubMed ID: 3871120 [TBL] [Abstract][Full Text] [Related]
3. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart. Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909 [TBL] [Abstract][Full Text] [Related]
4. Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species. Kula NS; Baldessarini RJ; Campbell A; Finklestein S; Ram VJ; Neumeyer JL Life Sci; 1984 Jun; 34(26):2567-75. PubMed ID: 6610812 [TBL] [Abstract][Full Text] [Related]
5. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Chiba K; Trevor AJ; Castagnoli N Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939 [TBL] [Abstract][Full Text] [Related]
6. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice. Jonsson G; Nwanze E; Luthman J; Sundström E Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380 [TBL] [Abstract][Full Text] [Related]
7. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. Shen RS; Abell CW; Gessner W; Brossi A FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242 [TBL] [Abstract][Full Text] [Related]
9. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW; Robertson DW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775 [TBL] [Abstract][Full Text] [Related]
11. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460 [TBL] [Abstract][Full Text] [Related]
12. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580 [TBL] [Abstract][Full Text] [Related]
13. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter. Clarke PB; Reuben M Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731 [TBL] [Abstract][Full Text] [Related]
14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon. Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619 [TBL] [Abstract][Full Text] [Related]
15. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse. Hallman H; Lange J; Olson L; Strömberg I; Jonsson G J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581 [TBL] [Abstract][Full Text] [Related]
16. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP. Andrews AM; Murphy DL J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity. Klein BG; Kirby ML; Freeborn ER; Bloomquist JR Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):591-608. PubMed ID: 11370999 [TBL] [Abstract][Full Text] [Related]
19. A new in vitro approach for investigating the MPTP effect on DA uptake. Barc S; Page G; Fauconneau B; Barrier L; Huguet F Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Sundström E; Jonsson G Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]